Contineum Therapeutics Financial Statements 2022-2024 | CTNM

Fifteen years of historical annual and quarterly income statements for Contineum Therapeutics (CTNM).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM20232022
$50.00$50.00$0
$0.00$0$0
$50.00$50.00$0
$25.14$27.60$16.89
$6.80$6.32$5.83
$0.00$0$0
$0.00$0$0
$18.06$16.08$-22.72
$6.80$7.09$-1.53
$24.87$23.17$-24.25
$0.73$0.45$0
$24.14$22.72$-24.25
$0.00$0$0
$24.14$22.72$-24.25
$0.00$0$0
$-11.56$3.15$-24.25
$18.00$16.07$-22.24
$18.06$16.08$-22.72
$-1.38$1.36$-10.81
$-3.10$0.08$-10.81

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
$0$0$0$50.00$0$0
$0$0$0$0$0$0
$0$0$0$50.00$0$0
$7.90$7.78$0$9.46$3.63$0
$3.04$2.15$0$1.60$1.48$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$-10.94$-9.93$0$38.94$-5.12$0
$1.94$1.51$0$3.36$0.29$0
$-9.01$-8.42$0$42.29$-4.82$0
$0$0.00$0$0.73$0$0
$-9.01$-8.42$0$41.56$-4.82$0
$0$0$0$0$0$0
$-9.01$-8.42$0$41.56$-4.82$0
$0$0$0$0$0$0
$-9.01$-8.42$0$5.87$-4.82$0
$-10.88$-9.87$0$38.76$-5.02$0
$-10.94$-9.93$0$38.94$-5.12$0
$-0.39$-3.55$0$2.56$-2.12$0
$-0.39$-3.55$0.00$0.84$-2.12$0.00